Prudential Financial
GMAB icon

Prudential Financial’s Genmab GMAB Stock Holding History

Prudential Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,971
Closed -$487K – 2436
2024
Q3 		$487K Buy
19,971
+244
+1% +$6.52K ﹤0.01% 2230
2024
Q2 		$496K Sell
19,727
-4,632
-19% -$131K ﹤0.01% 2185
2024
Q1 		$729K Sell
24,359
-23,652
-49% -$695K ﹤0.01% 1992
2023
Q4 		$1.53M Buy
48,011
+17,915
+60% +$562K ﹤0.01% 1606
2023
Q3 		$1.06M Buy
30,096
+8,644
+40% +$329K ﹤0.01% 1734
2023
Q2 		$815K Buy
21,452
+6,038
+39% +$241K ﹤0.01% 1911
2023
Q1 		$582K Sell
15,414
-3,917
-20% -$151K ﹤0.01% 2004
2022
Q4 		$819K Buy
19,331
+2,919
+18% +$120K ﹤0.01% 1802
2022
Q3 		$524K Buy
+16,412
New +$576K ﹤0.01% 2050

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Prudential Financial's GMAB Position: Q4 2024 in Review

Prudential Financial sold out of Genmab (GMAB) in Q4 2024, closing a stake of 19,971 shares — an estimated $487K sold.

Prudential Financial first reported a position in GMAB in Q3 2022 and held it in 9 quarters. The position peaked at $1.53M in Q4 2023. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Prudential Financial reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 19,971 Genmab shares in Q4 2024, an estimated $487K.
  • Prudential Financial first reported a position in Genmab in Q3 2022 and held it in 9 quarters.
  • Prudential Financial's Genmab position peaked at $1.53M in Q4 2023.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.